Evidence map›Paper›PMID 41868650›Full record

ArticleFrontiers in allergy2026

EUFOREA summit in Brussels 2025: inspiring the future of allergy and respiratory care.

S Lau, V Backer, G K Scadding, P J Barnes, M Bernal Sprekelsen, X Bertels, M Blaiss, E Borzova, M C Brüggen, L O Cardell and 37 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in allergy, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

47 authors.

S LauDepartment of Pediatric Respiratory Medicine, Immunology and Critical Care Medicine, Charité Universitaetsmedizin Berlin, Berlin, Germany.
V BackerDepartment of Otorhinolaryngology, Head & Neck Surgery, and Audiology, Rigshospitalet, Copenhagen University, Copenhagen, Denmark.
G K ScaddingDepartment of Allergy & Rhinology, Royal National ENT Hospital, London, United Kingdom.
P J BarnesNational Heart and Lung Institute, Imperial College London, London, United Kingdom.
M Bernal SprekelsenHospital Clinic, University of Barcelona, Barcelona, Spain.
X BertelsScientific Expert Team Members, The European Forum for Research and Education in Allergy and Airway Diseases, Brussels, Belgium.
M BlaissMedical College of Georgia at Augusta University, Augusta, GA, United States.
E BorzovaDermatology Division, Niigata University Graduate School of Medical and Dental Sciences (Medicine), Chuo-ku, Niigata.
M C BrüggenDepartment of Dermatology, University Hospital of Zurich, Zurich, Switzerland.
L O CardellDivision of ENT Diseases, Department of Clinical Sciences, Intervention and Technology, Karolinska Institutet, Stockholm, Sweden.
D M ContiAllergy and Clinical Immunology Research Unit, Department of Microbiology and Immunology, KU Leuven, Leuven, Belgium.
M CornetDepartment of Otorhinolaryngology, Alrijne Hospital, Leiderdorp, Netherlands.
E De CorsoOtolaryngology Head and Neck Surgery, A. Gemelli University Hospital Foundation IRCCS, Rome, Italy.
R DjukanovicFaculty of Medicine, University of Southampton, Southampton, United Kingdom.
W J FokkensDepartment of Otorhinolaryngology, Amsterdam University Medical Centres, Amsterdam, Netherlands.
A T FoxChildren's Allergy Service, Evelina London Children's Hospital, London, United Kingdom.
M GagaSection of Pulmonary and Critical Care Medicine, Hygeia Hospital, Athens, Greece.
P GevaertUpper Respiratory Diseases Research Group, University of Ghent, Gent, Belgium.
P GibsonDepartment of Respiratory and Sleep Medicine, John Hunter Hospital, Newcastle, NSW, Australia.
C L GrayDivision of Allergy, Department of Paediatrics and Child Health, University of Cape Town, Rondebosch, South Africa.
L G HeaneyWellcome-Wolfson Institute for Experimental Medicine, Belfast, United Kingdom.
E HefflerIRCCS Humanitas Research Hospital, Rozzano, Italy.
H J HoffmannDepartment of Clinical Medicine, University of Aarhus, Aarhus, Denmark.
C HopkinsDepartment of Rhinology and Skull Base Surgery, Guy's and St Thomas' Hospital NHS Foundation Trust, London, United Kingdom.
D JacksonGuy's Severe Asthma Centre, Guy's and St. Thomas' NHS Foundation Trust, and the School of Immunology and Microbial Sciences, King's College London, London, United Kingdom.
M JesenakDepartment of Pulmonology and Phthisiology, Department of Pediatrics, Department of Clinical Immunology and Allergology, Jessenius Faculty of Medicine in Martin, Comenius University in Bratislava, University Hospital in Martin, Martin, Slovakia.
P JohansenDepartment of Dermatology, University Hospital of Zurich, Zurich, Switzerland.
E KhalevaClinical and Experimental Sciences and Human Development and Health, Faculty of Medicine, University of Southampton, Southampton, United Kingdom.
S LeeDivision of Rhinology and Skull Base Surgery, Department of Otolaryngology-Head and Neck Surgery, Johns Hopkins School of Medicine, Baltimore, MD, United States.
M J MäkeläHUS Skin and Allergy Hospital, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.
E MelénDepartment of Clinical Science and Education Södersjukhuset, Karolinska Institutet and Sachs' Children and Youth Hospital, Stockholm, Sweden.
J MullolRhinology Unit and Smell Clinic, ENT Department, Hospital Clínic, IDIBAPS, Universitat de Barcelona, CIBERES, Barcelona, Spain.
A NietoHealth Research Institute, Hospital La Fe, Valencia, Spain.
I PavordRespiratory Medicine, NIHR Oxford Biomedical Research Centre, Nuffield Department of Medicine, University of Oxford, Oxford, United Kingdom.
A PetersDepartment of Medicine, Division of Allergy and Immunology, Northwestern University Feinberg School of Medicine, Chicago, IL, United States.
D PriceObservational and Pragmatic Research Institute, Singapore, Singapore.
S QuirceDepartment of Allergy, Hospital Universitario La Paz, IdiPAZ, Madrid, Spain.
D RyanAllergy and Respiratory Research Group, Usher Institute of Population Health Sciences and Informatics, University of Edinburgh, Edinburgh, United Kingdom.
S SchneiderDepartment of Otorhinolaryngology, Head and Neck Surgery, Vienna General Hospital, Medical University of Vienna, Vienna, Austria.
B SeniorDepartment of Otolaryngology/Head and Neck Surgery, University of North Carolina, Chapel Hill, NC, United States.
C M E ShirePatient Advisory Board of the European Forum for Research and Education in Allergy and Airway Diseases, Brussels, Belgium.
P SmithGriffth University, Southport, QLD, Australia.
T TeelingPatient Advisory Board of the European Forum for Research and Education in Allergy and Airway Diseases, Brussels, Belgium.
J C VirchowKlinik für Pneumologie, Allergologie und Internistische Intensivmedizin, Universitätsmedizin Rostock, Rostock, Germany.
V LundRoyal National Ear, Nose and Eastman Dental Hospital, London, United Kingdom.
U WahnDepartment of Pediatric Respiratory Medicine, Immunology and Critical Care Medicine, Charité Universitaetsmedizin Berlin, Berlin, Germany.
P W HellingsUpper Respiratory Diseases Research Group, University of Ghent, Gent, Belgium.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

EUFOREA, the European Forum for Research and Education in Allergy and Airways diseases, is an international non-for-profit organisation of physicians, patients, and other stakeholders committed to the improvement of outcomes for patients suffering from chronic inflammatory respiratory conditions through collaborative research, education, and targeted advocacy. In February 2025, EUFOREA hosted its biennial summit in Brussels, convening expert panels, its Patient Advisory Board, and a range of leadership representatives. This event was pivotal in establishing the research, educational, and advocacy priorities for the subsequent 2-year period, coinciding with the organisation's 10th anniversary in April 2025. Building on its core competencies, EUFOREA advances evidence-based clinical tools and educational initiatives designed to narrow the gap between emerging science and routine care. In alignment with the objective of enhancing global healthcare standards, the specialists' panels of chronic rhinosinusitis and European Position Paper on Rhinosinusitis and Nasal Polyps (EPOS), allergic rhinitis, asthma, allergen immunotherapy, and paediatrics have devised and detailed a comprehensive range of initiatives that address significant unmet needs within the domains of allergy and respiratory care. This document presents a summary of EUFOREA's future objectives, aspirations, and strategy, providing a clear direction for the coming years. It serves as a valuable resource for individuals and organisations involved in both the allergy and the respiratory sectors, offering a comprehensive overview of the association's plans and initiatives.

Indexed as

allergen immunotherapyasthmaCOPDEUFOREApaediatric allergyrhinitisrhinosinusitissummit

Identifiers

PMID41868650
PMCPMC13003419

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.